MaGiCAD was set up with two main aims:

1. Examine further the potential use of metabonomics and genomics as alternative diagnostics for coronary atherosclerosis to the angiogram.
2. Provide a large, well-characterised, bank of samples that can be used for basic science investigations into atherosclerosis.